(Q41025039)

English

Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials

scientific article published on 27 August 2015

Statements

Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials (English)
Florin Alexandru Caruntu
Manuela Curescu
Richard Skoien
Wayne Ghesquiere
Włodzimierz Mazur
Alejandro Soza
Francisco Fuster
Susan Greenbloom
Victoria Arama
Joseph Sasadeusz
Danielle Sullivan
Andrew Campbell
Thomas Podsadecki

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit